Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-06-08

FDA Approved: HALOPERIDOL — Supplemental Application (Fresenius Kabi USA, LLC)

View source ↗

Summary

The FDA approved a supplemental application for HALOPERIDOL LACTATE from Fresenius Kabi USA, LLC, authorizing changes to the marketed haloperidol product as a l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HALOPERIDOL LACTATE (HALOPERIDOL)

Snippet

SUPPL AP for HALOPERIDOL (HALOPERIDOL LACTATE)